Decision of actual problem of diffuse toxic goiter and thyroid cancer patients treatment and diagnostics in different regions of world
Abstract
About the Authors
A Romanchishendoktor med. nauk, professor, zaveduyushchiy kafedroy gospital'noy khirurgii s kursami travmatologii i VPKh GBOU VPO Sankt-Peterburgskaya Pediatricheskaya gosudarstvennaya meditsinskaya aka-demiya, rukovoditel' Tsentra khirurgii i onkologii organov endokrinnoy sistemy g. Sankt-Peterburga
K Vabalayte
assistent kafedry gospital'noy khirurgii s kursami travmatologii i VPKh GBOU VPO Sankt-Peterburgskaya Pediatricheskaya gosudarstvennaya meditsinskaya akademiya, Tsentr khirurgii i onkologii organov endokrinnoy sistemy g. Sankt-Peterburga
G Bagatiriay
doktor med. nauk, professor kafedry gospital'noy khirurgii s kursami travmatologii i VPKh GBOU VPO Sankt-Peterburgskaya Pediatricheskaya gosudarstvennaya meditsinskaya akademiya, Tsentr khirurgii i onkologii organov endokrinnoy sistemy g. Sankt-Peterburga
References
1. Волерт В.А. Диффузный токсический зоб у мужчин. Автореф. дис…канд. мед. наук. СПб., 2002.
2. Диагностика и лечение дифференцированного РЩЖ. Клинические рекомендации согласительной комиссии (с небольшими сокращениями). Вестн. хир. им. И.И. Грекова 2008;67 (3): 59–62.
3. Пирогов Н.И. Хирургический вопрос об экстирпации щитовидной железы. Дерпт,1831. 355–359.
4. Романчишен А.Ф. Клинико-патогенетические варианты новообразований щитовидной железы. СПб.: Наука,1992.
5. Романчишен А.Ф. Хирургия щитовидной и околощитовидных желез. СПб.:ИПК Вести, 2009.
6. Статистика злокачественных новообразований в России и странах СНГ в 2007 г. Вестн. РОНЦ им. Н.Н. Блохина 2009; 20(3), прил.1: 11.
7. Ainitaim A., Abouzeid M.E., Al-Sugair A. et al. No Difference Whether PET-CT is Done While on or Off Thyroxin among Differentiated Thyroid Cancer (DTC) Patients with High Thyroglobulin. World Congress on Thyroid Cancer. 2009.
8. Berry J. Diseases of the thyroid gland and their surgical treatment. London: J. & A. Churchill, 1901.
9. Billroth T. Die Allegmeine chirurgischen pathologie und therapie in Funfzig vorlesungen. Berlin, 1863.
10. Buchholtz A. wn. E. Bergmann. Berlin, 1913.
11. Carneiro dos Santas A.P., Reis C.F., Vieira C.U. The Antibody Fragment Library (SCFV) Generated from Well Differentiated Thyroid Tumors Selected in Thyroid Cells. World Congress on Thyroid Cancer, 2009.
12. Chnkrabarti A., Joseph S., Ramamurthy S. et al. Role of Neck Ultrasound Scan to Detect Local Recurrence in Thyroid Cancer Patients with Undetectable Thyroglobulin Even in the Absence of Thyroglobulin Antibody. World Congress on Thyroid Cancer, 2009.
13. Cumbronero E., Chen-Ku C. H., Chinchilla A. et al. Completeness of Thyroidectomy Based on Postoperative Thyroglobulin Levels and its Predictive Value. World Congress on Thyroid Cancer, 2009.
14. Сramer J.D., Fu P., Harth K.C. et al. Analysis of the rising incidence of thyroid cancer using thr Surveillance, Epidemiology and End Results national cancer data registry. Surgery 2010; 148 (6): 1147–1153.
15. Harvard Continuing Education Course “Surgery Thyroid & Parathyroid Glands” Boston (MA. USA), 2008. November 7–9.
16. Hay J.D. Does Radioiodine Remnant Ablation really “Improve Outcome” in Low-Risk Papillary Cancer Patients, Who have Only a 1% Risk of Dying from the Disease? World Congress on Thyroid Cancer, 2009.
17. Ladenson P.W., Singer P.A., Ain K. B. et al. American Thyroid Association Guidelines for Detection of Thyroid Dysfunction. Arch. Intern. Med. 2000;. 160: 1573–1575.
18. Lee C. Surgical management of Grave’s disease up-to-date in Taiwan. 12th Congress of Asian Association of Endocrine Surgeons, 2010. March 23–24.
19. McCaffrey T.V., Lipton R.J. Thyroid carcinoma invading the upper aerodigestive system. Laryngoscope 1990; 100: 824.
20. Moss L. UK Survey of Differentiated Thyroid Cancer Management. World Congress on Thyroid Cancer, 2009.
21. Noguchi H., Uchino S., Yamashita H. et al. Surgical management of Grave’s disease, past and future. 12th Congress of Asian Association of Endocrine Surgeons, 2010. March 23–24.
22. O’Toole L. Are We Under-Treating Low Risk Thyroid Cancer Patients? World Congress on Thyroid Cancer, 2009.
23. Parkyn R.F. Surgical management of Graves’ disease in Australia. 12th Congress of Asian Association of Endocrine Surgeons, 2010. March 23–24.
24. Pathak K.A. Has the Use of Radioactive Iodine Impacted the Outcome of High Risk Differentiated Thyroid Cancer. World Congress on Thyroid Cancer, 2009.
25. Romaldini J.H. Case selection and restrictions recommended to patients with hyperthyroidism in South America. Thyroid 1997; 7(2): 225–228.
26. Rubino C., Vathaire D., Dottorini M. et al. Second primary malignancy in Thyroid Cancer Patients. Brit. J. Cancer 2003; 89: 1638.
27. Serouya S. “Complete” Total Thyroidectomy is Achievable. World Congress on Thyroid Cancer, 2009.
28. Sugino K., Ito K., Nagahama M. et al. Surgical management of Graves’ disease - surgical outcome and current policy in our institution. 12th Congress of Asian Association of Endocrine Surgeons, 2010. March 23–24.
29. Tan W.B., Tay C., Tan C. et al. Surgical management of Graves’ disease. Results and changing trend in single institution over a 19-year period. 12th Congress of Asian Association of Endocrine Surgeons, 2010. March 23–24.
30. Tominaga T., Yokoyama N., Nagataki S. et al. International differences in approaches to 131I therapy for Graves’ disease: case selection and restrictions recommended to patients in Japan, Korea, and China. Clin. Endocrinol. (Oxf.) 1998; 49(1): 21–28.
31. Vaismnn A., Orlov S., Yip J. et al. Update on the Use of Post-Surgical Stimulated Thyroglobulin in Assisting Radioactive Remnant Ablation Decision-Making for Low Risk Well-Differentiated Thyroid Carcinoma. World Congress on Thyroid Cancer, 2009.
32. Walsh J.P. Management of Graves’ disease in Australia. Aust. N. Z. J. Med. 2000; 30(5): 559–566.
33. Witt R. What is New in the ATA (American Thyroid Association) Guidelines// 4th World Congress of International Federation of Head and Neck Oncologic Societies, 2010.
Review
For citations:
, , Decision of actual problem of diffuse toxic goiter and thyroid cancer patients treatment and diagnostics in different regions of world. Clinical and experimental thyroidology. 2012;8(1):19-27. (In Russ.)